PRMA Consulting delivers global, regional, and local market access solutions to maximize product potential

PRMA Consulting thought leadership

NEWAMNOG 15 May 2013

Benefit assessment in Germany: how well are you really prepared?

Manufacturers face many challenges in understanding and meeting the demanding requirements of benefit assessment, introduced as part of the AMNOG legislation in January 2011. Particular issues lie in the appropriate comparator, the relevance of endpoints, particularly...

Read the full article...

Companion diagnostics in oncology 26 Mar 2013

Overcoming market access challenges for companion diagnostics in oncology

PRMA Insights: Market Access Success for Companion Diagnostic–Drug Pairings in Oncology is launched today, the eighth publication in the Insights series. This strategic resource is an essential handbook for manufacturers bringing a drug–test pairing to market. It has been...

Read the full article...

Pricing and reimbursement

Will your clinical trial results meet the requirements of EU payors?

Effective European market access requires detailed understanding of the evidence required to demonstrate value and therefore support reimbursement. The requirements relating to endpoints, relevant patient subpopulations, comparator, quality of life data, and economic...

Read the full article...

nsclc

How will the maintenance treatment paradigm affect the NSCLC market?

Maintenance treatment has emerged as a new paradigm in the treatment of advanced NSCLC: with the aim of maintaining tumor shrinkage in patients with stable disease or following response to platinum-based...

Read the full article...

PRMA Consulting update

WebinarSummer 2013 AMNOG - pricing and reimbursement

The impact of AMNOG on pricing and reimbursement

Join our expert, Monika Behrens, for a webinar and Q&A

Watch the introduction and register

Conference18–22 May 2013 ISPOR

Join PRMA Consulting at ISPOR
Stand 2025–2026

Join us in New Orleans, where we would be delighted to talk you through our new PRMA Insights on companion diagnostics and other titles in the series.

Contact us to set up a meeting

Just published26 March 2013Companion diagnostics in oncology resource

Watch the introduction to the latest PRMA Insights resource

Market Access Success for Companion Diagnostic–Drug Pairings in Oncology

Watch online | Download the brochure

Contact us
"PRMA Consulting is the best consultancy we've worked with in every way – flexibility, responsiveness, adherence to timelines and quality of the work." Head of Market Access, Health Economics, and Pricing. Top 30 global pharmaceutical company

PRMA Insights: Pricing and reimbursement success

PRMA Insights provide in-depth understanding of current and future market access realities, developed by industry-experienced experts with comprehensive cross-functional knowledge. Critical insight into the clinical and payor landscape is supported by actionable strategic insights, providing a cornerstone on which to build a successful market access strategy.

PRMA Consulting logo

Head Office

Email: info@prmaconsulting.com
Tel: +44 (0) 1252 786284
PRMA Consulting, Cygnus House, 1 Waterfront Business Park, Fleet, Hampshire GU51 3QT, UK

Registered in England & Wales | Company number 05893400
PRMA Consulting privacy policy